Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.

Piulats JM, Vidal A, García-Rodríguez FJ, Muñoz C, Nadal M, Moutinho C, Martínez-Iniesta M, Mora J, Figueras A, Guinó E, Padullés L, Aytés À, Molleví DG, Puertas S, Martínez-Fernández C, Castillo W, Juliachs M, Moreno V, Muñoz P, Stefanovic M, Pujana MA, Condom E, Esteller M, Germà JR, Capella G, Farré L, Morales A, Viñals F, García-Del-Muro X, Cerón J, Villanueva A.

Clin Cancer Res. 2018 Apr 4. doi: 10.1158/1078-0432.CCR-17-1898. [Epub ahead of print]

PMID:
29618620
2.

Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.

Jiménez-Altayó F, Meirelles T, Crosas-Molist E, Sorolla MA, Del Blanco DG, López-Luque J, Mas-Stachurska A, Siegert AM, Bonorino F, Barberà L, García C, Condom E, Sitges M, Rodríguez-Pascual F, Laurindo F, Schröder K, Ros J, Fabregat I, Egea G.

Free Radic Biol Med. 2018 Apr;118:44-58. doi: 10.1016/j.freeradbiomed.2018.02.023. Epub 2018 Feb 20.

PMID:
29471108
3.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Pereira C, Gimenez-Xavier P, Pros E, Pajares MJ, Moro M, Gomez A, Navarro A, Condom E, Moran S, Gomez-Lopez G, Graña O, Rubio-Camarillo M, Martinez-Martí A, Yokota J, Carretero J, Galbis JM, Nadal E, Pisano D, Sozzi G, Felip E, Montuenga LM, Roz L, Villanueva A, Sanchez-Cespedes M.

Clin Cancer Res. 2017 Jun 15;23(12):3203-3213. doi: 10.1158/1078-0432.CCR-16-1946. Epub 2017 Mar 16.

4.

Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.

Romero OA, Verdura S, Torres-Diz M, Gomez A, Moran S, Condom E, Esteller M, Villanueva A, Sanchez-Cespedes M.

Oncogene. 2017 Mar 2;36(9):1287-1296. doi: 10.1038/onc.2016.296. Epub 2016 Sep 5.

PMID:
27593925
5.

The DNA methylation drift of the atherosclerotic aorta increases with lesion progression.

Valencia-Morales Mdel P, Zaina S, Heyn H, Carmona FJ, Varol N, Sayols S, Condom E, Ramírez-Ruz J, Gomez A, Moran S, Lund G, Rodríguez-Ríos D, López-González G, Ramírez-Nava M, de la Rocha C, Sanchez-Flores A, Esteller M.

BMC Med Genomics. 2015 Feb 27;8:7. doi: 10.1186/s12920-015-0085-1.

6.

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Bonastre E, Verdura S, Zondervan I, Facchinetti F, Lantuejoul S, Chiara MD, Rodrigo JP, Carretero J, Condom E, Vidal A, Sidransky D, Villanueva A, Roz L, Brambilla E, Savola S, Sanchez-Cespedes M.

Cancer Res. 2015 Apr 1;75(7):1287-97. doi: 10.1158/0008-5472.CAN-14-2444.

7.

Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.

Crosas-Molist E, Meirelles T, López-Luque J, Serra-Peinado C, Selva J, Caja L, Gorbenko Del Blanco D, Uriarte JJ, Bertran E, Mendizábal Y, Hernández V, García-Calero C, Busnadiego O, Condom E, Toral D, Castellà M, Forteza A, Navajas D, Sarri E, Rodríguez-Pascual F, Dietz HC, Fabregat I, Egea G.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):960-72. doi: 10.1161/ATVBAHA.114.304412. Epub 2015 Jan 15.

8.

Multidrug resistance protein 1 localization in lipid raft domains and prostasomes in prostate cancer cell lines.

Gomà A, Mir R, Martínez-Soler F, Tortosa A, Vidal A, Condom E, Pérez-Tomás R, Giménez-Bonafé P.

Onco Targets Ther. 2014 Dec 5;7:2215-25. doi: 10.2147/OTT.S69530. eCollection 2014.

9.

Involvement of potassium channels in the progression of cancer to a more malignant phenotype.

Comes N, Serrano-Albarrás A, Capera J, Serrano-Novillo C, Condom E, Ramón Y Cajal S, Ferreres JC, Felipe A.

Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2477-92. doi: 10.1016/j.bbamem.2014.12.008. Epub 2014 Dec 14. Review.

10.

Ecto-nucleotidases activities in the contents of ovarian endometriomas: potential biomarkers of endometriosis.

Texidó L, Romero C, Vidal A, García-Valero J, Fernández Montoli ME, Baixeras N, Condom E, Ponce J, García-Tejedor A, Martín-Satué M.

Mediators Inflamm. 2014;2014:120673. doi: 10.1155/2014/120673. Epub 2014 Sep 3.

11.

DNA methylation map of human atherosclerosis.

Zaina S, Heyn H, Carmona FJ, Varol N, Sayols S, Condom E, Ramírez-Ruz J, Gomez A, Gonçalves I, Moran S, Esteller M.

Circ Cardiovasc Genet. 2014 Oct;7(5):692-700. doi: 10.1161/CIRCGENETICS.113.000441. Epub 2014 Aug 4.

12.

Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology.

Oliveras A, Roura-Ferrer M, Solé L, de la Cruz A, Prieto A, Etxebarria A, Manils J, Morales-Cano D, Condom E, Soler C, Cogolludo A, Valenzuela C, Villarroel A, Comes N, Felipe A.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1522-30. doi: 10.1161/ATVBAHA.114.303801. Epub 2014 May 22.

13.

High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.

Aliagas E, Vidal A, Texidó L, Ponce J, Condom E, Martín-Satué M.

Mediators Inflamm. 2014;2014:509027. doi: 10.1155/2014/509027. Epub 2014 Feb 24.

14.

The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.

Juliachs M, Muñoz C, Moutinho CA, Vidal A, Condom E, Esteller M, Graupera M, Casanovas O, Germà JR, Villanueva A, Viñals F.

Clin Cancer Res. 2014 Feb 1;20(3):658-67. doi: 10.1158/1078-0432.CCR-13-1131. Epub 2013 Nov 25.

15.

YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression.

Mir R, Stanzani E, Martinez-Soler F, Villanueva A, Vidal A, Condom E, Ponce J, Gil J, Tortosa A, Giménez-Bonafé P.

Gynecol Oncol. 2014 Jan;132(1):211-20. doi: 10.1016/j.ygyno.2013.11.013. Epub 2013 Nov 19.

PMID:
24262875
16.

The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer.

Comes N, Bielanska J, Vallejo-Gracia A, Serrano-Albarrás A, Marruecos L, Gómez D, Soler C, Condom E, Ramón Y Cajal S, Hernández-Losa J, Ferreres JC, Felipe A.

Front Physiol. 2013 Oct 10;4:283. doi: 10.3389/fphys.2013.00283. Review.

17.

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.

Juliachs M, Vidal A, Del Muro XG, Piulats JM, Condom E, Casanovas O, Graupera M, Germà JR, Villanueva A, Viñals F.

BMC Cancer. 2013 Aug 10;13:382. doi: 10.1186/1471-2407-13-382.

18.

Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy.

Vallejo-Gracia A, Bielanska J, Hernández-Losa J, Castellví J, Ruiz-Marcellan MC, Ramón y Cajal S, Condom E, Manils J, Soler C, Comes N, Ferreres JC, Felipe A.

J Leukoc Biol. 2013 Oct;94(4):779-89. doi: 10.1189/jlb.0213094. Epub 2013 Jul 11.

PMID:
23847097
19.

ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.

Juliachs M, Castillo-Ávila W, Vidal A, Piulats JM, Garcia Del Muro X, Condom E, Hernández-Losa J, Teixidó C, Pandiella A, Graupera M, Casanovas O, Germà JR, Villanueva A, Viñals F.

Int J Cancer. 2013 Jul;133(1):235-46. doi: 10.1002/ijc.28009. Epub 2013 Feb 12.

20.

Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium.

Aliagas E, Vidal A, Torrejón-Escribano B, Taco Mdel R, Ponce J, de Aranda IG, Sévigny J, Condom E, Martín-Satué M.

Purinergic Signal. 2013 Jun;9(2):227-37. doi: 10.1007/s11302-012-9345-0. Epub 2012 Dec 6.

21.

Prostatic sarcoma after conservative treatment with brachytherapy for low-risk prostate cancer.

Domínguez A, Piulats JM, Suárez JF, Condom E, Castells M, Camps N, García Del Muro FX, Franco E.

Acta Oncol. 2013 Aug;52(6):1215-6. doi: 10.3109/0284186X.2012.734927. Epub 2012 Oct 24. No abstract available.

PMID:
23095143
22.

Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.

Mir R, Tortosa A, Martinez-Soler F, Vidal A, Condom E, Pérez-Perarnau A, Ruiz-Larroya T, Gil J, Giménez-Bonafé P.

Int J Cancer. 2013 Apr 1;132(7):1525-36. doi: 10.1002/ijc.27832. Epub 2012 Oct 11.

23.

Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer.

Vidal A, Muñoz C, Guillén MJ, Moretó J, Puertas S, Martínez-Iniesta M, Figueras A, Padullés L, García-Rodriguez FJ, Berdiel-Acer M, Pujana MA, Salazar R, Gil-Martin M, Martí L, Ponce J, Molleví DG, Capella G, Condom E, Viñals F, Huertas D, Cuevas C, Esteller M, Avilés P, Villanueva A.

Clin Cancer Res. 2012 Oct 1;18(19):5399-411. doi: 10.1158/1078-0432.CCR-12-1513. Epub 2012 Aug 15.

24.

Increased voltage-dependent K+ channel Kv1.3 and Kv1.5 expression correlates with leiomyosarcoma aggressiveness.

Bielanska J, Hernández-Losa J, Moline T, Somoza R, Ramón Y Cajal S, Condom E, Ferreres JC, Felipe A.

Oncol Lett. 2012 Aug;4(2):227-230. Epub 2012 May 16.

25.

Primary large-cell neuroendocrine carcinoma of the penis: association with human papilloma virus infection.

Landeyro J, Garcia-Fontgivell JF, Condom E, Sirvent JJ.

Histopathology. 2012 Aug;61(2):319-20. doi: 10.1111/j.1365-2559.2012.04256.x. Epub 2012 Jun 13. No abstract available.

PMID:
22690881
26.

Human skin model containing melanocytes: essential role of keratinocyte growth factor for constitutive pigmentation-functional response to α-melanocyte stimulating hormone and forskolin.

Duval C, Chagnoleau C, Pouradier F, Sextius P, Condom E, Bernerd F.

Tissue Eng Part C Methods. 2012 Dec;18(12):947-57. doi: 10.1089/ten.TEC.2011.0676. Epub 2012 Jul 2.

PMID:
22646688
27.

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer.

Romero OA, Setien F, John S, Gimenez-Xavier P, Gómez-López G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M.

EMBO Mol Med. 2012 Jul;4(7):603-16. doi: 10.1002/emmm.201200236. Epub 2012 Apr 11.

28.

Epigenetic disruption of cadherin-11 in human cancer metastasis.

Carmona FJ, Villanueva A, Vidal A, Muñoz C, Puertas S, Penin RM, Gomà M, Lujambio A, Piulats JM, Mesía R, Sánchez-Céspedes M, Manós M, Condom E, Eccles SA, Esteller M.

J Pathol. 2012 Oct;228(2):230-40. doi: 10.1002/path.4011. Epub 2012 Jul 26.

29.

Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas.

Bielanska J, Hernández-Losa J, Moline T, Somoza R, Ramón y Cajal S, Condom E, Ferreres JC, Felipe A.

Cancer Invest. 2012 Mar;30(3):203-8. doi: 10.3109/07357907.2012.654872.

PMID:
22360360
30.

Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.

Felipe A, Bielanska J, Comes N, Vallejo A, Roig S, Ramón Y Cajal S, Condom E, Hernández-Losa J, Ferreres JC.

Curr Med Chem. 2012;19(5):661-74. Review.

PMID:
22204339
31.

Pigmented paget disease of the breast nipple with underlying infiltrating carcinoma: a case report and review of the literature.

Soler T, Lerin A, Serrano T, Masferrer E, García-Tejedor A, Condom E.

Am J Dermatopathol. 2011 Jul;33(5):e54-7. doi: 10.1097/DAD.0b013e3181fd1eec. Review.

PMID:
21587034
32.

Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus.

Bielanska J, Hernández-Losa J, Moline T, Somoza R, Ramón Y Cajal S, Condom E, Ferreres JC, Felipe A.

Cell Physiol Biochem. 2010;26(2):219-26. doi: 10.1159/000320528. Epub 2010 Aug 24.

33.

Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer.

Bielanska J, Hernández-Losa J, Pérez-Verdaguer M, Moline T, Somoza R, Ramón Y Cajal S, Condom E, Ferreres JC, Felipe A.

Curr Cancer Drug Targets. 2009 Dec;9(8):904-14.

PMID:
20025600
34.

Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.

Castillo-Avila W, Piulats JM, Garcia Del Muro X, Vidal A, Condom E, Casanovas O, Mora J, Germà JR, Capellà G, Villanueva A, Viñals F.

Clin Cancer Res. 2009 May 15;15(10):3384-95. doi: 10.1158/1078-0432.CCR-08-2170. Epub 2009 May 5.

35.

Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer.

Abril J, de Heredia ML, González L, Clèries R, Nadal M, Condom E, Aguiló F, Gómez-Zaera M, Nunes V.

Prostate. 2008 Jul 1;68(10):1086-96. doi: 10.1002/pros.20771.

PMID:
18409190
36.

Potassium channels are a new target field in anticancer drug design.

Villalonga N, Ferreres JC, Argilés JM, Condom E, Felipe A.

Recent Pat Anticancer Drug Discov. 2007 Nov;2(3):212-23. Review.

PMID:
18221064
37.

Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.

Solé X, Hernández P, de Heredia ML, Armengol L, Rodríguez-Santiago B, Gómez L, Maxwell CA, Aguiló F, Condom E, Abril J, Pérez-Jurado L, Estivill X, Nunes V, Capellá G, Gruber SB, Moreno V, Pujana MA.

BMC Genomics. 2008 Jan 11;9:12. doi: 10.1186/1471-2164-9-12.

38.

Aneuploidy of chromosome Y in prostate tumors and seminal vesicles: a possible sign of aging rather than an indicator of carcinogenesis?

Nadal M, Pera G, Pujadas J, Abril J, González L, Aguiló F, Condom E, Gómez-Zaera M, Nunes V.

Mol Carcinog. 2007 Jul;46(7):543-52.

PMID:
17295237
39.

Potassium channels: new targets in cancer therapy.

Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martínez-Mármol R, Solé L, Ferreres JC, Condom E.

Cancer Detect Prev. 2006;30(4):375-85. Epub 2006 Sep 12. Review.

PMID:
16971052
40.

Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study.

Alameda F, Munné A, Baró T, Iglesias M, Condom E, Lloreta-Trull J, Serrano S.

Ultrastruct Pathol. 2006 May-Jun;30(3):193-205.

PMID:
16825121
41.

Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients.

Gómez-Zaera M, Abril J, González L, Aguiló F, Condom E, Nadal M, Nunes V.

Mutat Res. 2006 Mar 20;595(1-2):42-51.

PMID:
16472830
42.

Tissue imprints or primary cultures: which strategy to use to study cytogenetic clonality?

Nadal M, Pera G, Gómez-Zaera M, Abril J, Suárez JF, Aguiló F, Condom E, Nunes V.

Diagn Mol Pathol. 2005 Dec;14(4):243-6.

PMID:
16319695
43.

Subperiosteal leiomyosarcoma of the tibia.

Narváez JA, De Lama E, Portabella F, Ortega R, Condom E.

Skeletal Radiol. 2005 Jan;34(1):42-6. Epub 2004 Oct 2.

PMID:
15635482
44.

Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression.

Erill N, Colomer A, Verdú M, Román R, Condom E, Hannaoui N, Banús JM, Cordon-Cardo C, Puig X.

Diagn Mol Pathol. 2004 Dec;13(4):217-23.

PMID:
15538112
45.

KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: expression associated with testis pathologies.

Tsevi I, Vicente R, Grande M, López-Iglesias C, Figueras A, Capellà G, Condom E, Felipe A.

J Cell Physiol. 2005 Feb;202(2):400-10.

PMID:
15389592
46.

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR.

Cancer. 2004 May 1;100(9):1859-67.

47.

Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.

Diestra JE, Condom E, Del Muro XG, Scheffer GL, Pérez J, Zurita AJ, Muñoz-Seguí J, Vigués F, Scheper RJ, Capellá G, Germà-Lluch JR, Izquierdo MA.

J Urol. 2003 Oct;170(4 Pt 1):1383-7.

PMID:
14501774
48.

Importance of tumoral markers in donors: study of prostate-specific antigen.

González-Segura C, Pascual M, Cañizares R, García-Huete L, Torras J, Riera L, Condom E.

Transplant Proc. 2003 Aug;35(5):1647-9.

PMID:
12962743
49.

Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.

Zurita AJ, Diestra JE, Condom E, García Del Muro X, Scheffer GL, Scheper RJ, Pérez J, Germà-Lluch JR, Izquierdo MA.

Br J Cancer. 2003 Mar 24;88(6):879-86.

50.

CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors.

Ordi J, Romagosa C, Tavassoli FA, Nogales F, Palacin A, Condom E, Torné A, Cardesa A.

Am J Surg Pathol. 2003 Feb;27(2):178-86.

PMID:
12548163

Supplemental Content

Loading ...
Support Center